The oral weight-loss drug introduced by Novo Nordisk this year in the U.S. is quickly being adopted. Analysts pointed to data ...

Popular weight-loss drug Wegovy is now available in pill form in the United States. Novo Nordisk, the Danish drugmaker behind Wegovy and the GLP-1 drug Ozempic, announced on Monday that the starting ...

There are two drugs on the market - semaglutide, marketed under the brand name Wegovy, and tirzepatide, sold as Mounjaro.

The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve adherence and boost long-term outcomes.

Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting ...

The monthly out-of-pocket cost is less than the $349 price for monthly injections, but the savings vary by dose.

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Patients who discontinue popular weight-loss medications like Ozempic and Wegovy typically regain the weight they lost within ...

About half (53%) of Americans say they hear or read about Ozempic, Wegovy and similar drugs extremely or very often.

Amazon starts to offer Wegovy weight loss pill to customers - The new oral Wegovy, launched this week, contains semaglutide, the same active ingredient as injectable Wegovy and Ozempic ...

The medication, available at a lower cost, is an alternative to injections and increases accessibility for patients, some doctors say.

The GLP-1 medication is now available via injection and pill.